tiprankstipranks
Innate Pharma partners with IFLI to study IPH6501, to receive $3M upfront
PremiumThe FlyInnate Pharma partners with IFLI to study IPH6501, to receive $3M upfront
2M ago
Innate Pharma publishes IPH6501 data in Science Immunology
Premium
The Fly
Innate Pharma publishes IPH6501 data in Science Immunology
2M ago
Innate Pharma appoints Jonathan Dickinson as CEO
Premium
The Fly
Innate Pharma appoints Jonathan Dickinson as CEO
4M ago
Innate Pharma provides clarification regarding SAR443579 designation
PremiumThe FlyInnate Pharma provides clarification regarding SAR443579 designation
8M ago
Innate Pharma doses first patient in Sanofi-sponsored trial of SAR443579
Premium
The Fly
Innate Pharma doses first patient in Sanofi-sponsored trial of SAR443579
10M ago
Innate Pharma announces first patient dosed in IPH6501 trial
Premium
The Fly
Innate Pharma announces first patient dosed in IPH6501 trial
11M ago
Innate announces updated efficacy, safety results from SAR443579 / IPH6101 study
PremiumThe FlyInnate announces updated efficacy, safety results from SAR443579 / IPH6101 study
1y ago
Innate Pharma announces partial clinical hold on lacutamab IND placed by FDA
Premium
The Fly
Innate Pharma announces partial clinical hold on lacutamab IND placed by FDA
1y ago
Innate Pharma reports encore presentation of TELLOMAK Phase 2 study results
Premium
The Fly
Innate Pharma reports encore presentation of TELLOMAK Phase 2 study results
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100